Circulating Tumor Cells as a Predictive Biomarker in Patients With Hormone-sensitive Prostate Cancer

Initial CTC values predict the duration and magnitude of response to hormonal therapy. CTC enumeration may identify patients at risk of progression to CRPC before initiation of androgen deprivation therapy.